Abstract

BackgroundThe growing interest in antibody-drug conjugates (ADCs) as promising therapies for multiple cancer types highlights the need for accurate approaches to detect ADC targets.1 2 While the conventional method to...

Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call